Redhill Biopharma Ltd. carried $900K in long-term debt against $4.0M in cash and equivalents at the end of fiscal year 2025. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Redhill Biopharma Ltd. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RDHL Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RDHL Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'256-K/A | Q4'246-K/A | Q2'246-K | Q4'2320-F | Q2'236-K | Q4'2220-F | Q2'226-K | Q4'2120-F | Q2'216-K | Q4'2020-F | Q2'206-K | Q4'1920-F |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $83.6M+2.7% | $83.2M+5.0% | $81.4M | $79.2M | N/A |
| Cash & Equivalents | $2.9M-60.6% | $4.6M-17.1% | $7.3M+4.0% | $5.6M-72.1% | $7.0M-74.1% | $20.0M-32.3% | $27.0M-47.9% | $29.5M+0.6% | $51.8M+132.7% | $29.3M+0.9% | $22.3M+147.6% | $29.0M+0.1% |
RDHL files its annual report on Form 20-F and its quarterly results on Form 6-K, and SEC's XBRL data holds no figures from those 6-K reports, so the quarterly figures here stop at the quarter ended June 30, 2025, while the annual figures run through FY2025.
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Redhill Biopharma Ltd. financials
Frequently Asked Questions
What was Redhill Biopharma Ltd.'s long-term debt in fiscal year 2025?
Redhill Biopharma Ltd. carried $900K in long-term debt against $4.0M in cash and equivalents at the end of fiscal year 2025.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Redhill Biopharma Ltd. (RDHL) reported on that line in every period on record.